Takeshita, A.; Asou, N.; Atsuta, Y.; Furumaki, H.; Sakura, T.; Ueda, Y.; Sawa, M.; Dobashi, N.; Taniguchi, Y.; Suzuki, R.;
et al. Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature. Cancers 2020, 12, 1444.
https://doi.org/10.3390/cancers12061444
AMA Style
Takeshita A, Asou N, Atsuta Y, Furumaki H, Sakura T, Ueda Y, Sawa M, Dobashi N, Taniguchi Y, Suzuki R,
et al. Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature. Cancers. 2020; 12(6):1444.
https://doi.org/10.3390/cancers12061444
Chicago/Turabian Style
Takeshita, Akihiro, Norio Asou, Yoshiko Atsuta, Hiroaki Furumaki, Toru Sakura, Yasunori Ueda, Masashi Sawa, Nobuaki Dobashi, Yasuhiro Taniguchi, Rikio Suzuki,
and et al. 2020. "Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature" Cancers 12, no. 6: 1444.
https://doi.org/10.3390/cancers12061444
APA Style
Takeshita, A., Asou, N., Atsuta, Y., Furumaki, H., Sakura, T., Ueda, Y., Sawa, M., Dobashi, N., Taniguchi, Y., Suzuki, R., Nakagawa, M., Tamaki, S., Hagihara, M., Fujimaki, K., Minamiguchi, H., Fujita, H., Yanada, M., Maeda, Y., Usui, N.,
... the Japan Adult Leukemia Study Group.
(2020). Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature. Cancers, 12(6), 1444.
https://doi.org/10.3390/cancers12061444
